FDA Commissioner, Dr. Stephen Hahn, told the Financial Times that the organization would consider emergency use authorization for a Covid-19 vaccine before Phase 3 trials were completed
Covid-19 vaccine: FDA could consider authorization before Phase 3 trials are over, Financial Times reports
More Stories
Record Korean Cases; Trader’s Guide to Rollout: Virus Update
California Hits Record; Trader’s Guide to Rollout: Virus Update
AstraZeneca to Buy Alexion for $39 Billion in Rare-Disease Push